Eton entered an exclusive licensing agreement with Aquestive for LIBERVANT buccal film, targeting a U.S. seizure rescue market exceeding $450 million annually with an anticipated April 2027 commercial launch.
Eton entered an exclusive licensing agreement with Aquestive for LIBERVANT buccal film, targeting a U.S. seizure rescue market exceeding $450 million annually with an anticipated April 2027 commercial launch.